Is QuidelOrtho Corp (QDEL) Halal?

NASDAQ Healthcare United States $1.0B
✗ NOT HALAL
Confidence: 90/100
QuidelOrtho Corp (QDEL) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 199.8% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. QuidelOrtho Corp operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 199.8%
/ 30%
12.0%
/ 30%
40.3%
/ 30%
0.08%
/ 5%
✗ NOT HALAL
DJIM 199.8%
/ 33%
12.0%
/ 33%
40.3%
/ 33%
0.08%
/ 5%
✗ NOT HALAL
MSCI 49.1%
/ 33%
2.9%
/ 33%
9.9%
/ 33%
0.08%
/ 5%
✗ NOT HALAL
S&P 199.8%
/ 33%
12.0%
/ 33%
40.3%
/ 33%
0.08%
/ 5%
✗ NOT HALAL
FTSE 49.1%
/ 33%
2.9%
/ 33%
9.9%
/ 50%
0.08%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-16.69
P/B Ratio
0.5
EV/EBITDA
6.6
EV: $3.7B
Revenue
$2.7B
Growth: 2.2%
Beta
0.8
Average volatility
Current Ratio
1.5

Profitability

Gross Margin 46.8%
Operating Margin 4.0%
Net Margin -41.5%
Return on Equity (ROE) -46.1%
Return on Assets (ROA) 1.3%

Cash Flow & Balance Sheet

Operating Cash Flow$105M
Free Cash Flow-$83M
Total Debt$2.8B
Debt-to-Equity148.6
Current Ratio1.5
Total Assets$5.8B

Price & Trading

Last Close$15.60
50-Day MA$23.47
200-Day MA$26.62
Avg Volume1.2M
Beta0.8
52-Week Range
$14.45
$38.99

About QuidelOrtho Corp (QDEL)

CEO
Mr. Brian J. Blaser
Employees
6,500
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$1.0B
Currency
USD

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is QuidelOrtho Corp (QDEL) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), QuidelOrtho Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is QuidelOrtho Corp's debt ratio?

QuidelOrtho Corp's debt ratio is 199.8% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 49.1%.

What are QuidelOrtho Corp's key financial metrics?

QuidelOrtho Corp has a market capitalization of $1.0B, and revenue of $2.7B. The company maintains a gross margin of 46.8% and a net margin of -41.5%. Return on equity stands at -46.1%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.